Reply to 'Rituximab activity in CD20-positive multiple myeloma'
- PMID: 17972948
- DOI: 10.1038/sj.leu.2405011
Reply to 'Rituximab activity in CD20-positive multiple myeloma'
Comment on
-
Rituximab in CD20 positive multiple myeloma.Leukemia. 2008 May;22(5):1082-3. doi: 10.1038/sj.leu.2405010. Epub 2007 Nov 1. Leukemia. 2008. PMID: 17972949 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
